• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Brigatinib-[d8]

General Information
Catalog: BLP-022281
CAS: 2055306-74-4
Molecular Formula: C29H31D8ClN7O2P
Molecular Weight: 592.15
Chemical Structure
Brigatinib-[d8]
Description Brigatinib-D8 is a deuterium labelled Brigatinib (B677713), which is a tyrosine kinase receptor Mer (MERTK) inhibitor and can be used in combination with epidermal growth factor receptor (EGFR) inhibitors for the treatment of cancer.
Synonyms (2-((5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl-2,2,3,3,5,5,6,6-d8)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine Oxide; 5-Chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl-2,2,3,3,5,5,6,6-d8)-1-piperidinyl]phenyl]-2,4-pyrimidinediamine

Interested in our Service & Products?
Need detailed information?

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All Rights Reserved.
Inquiry Basket